Insider Transactions by PARMAR KUSH

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SKYESkye Bioscience, Inc.PARMAR KUSH10% OwnerMar 13, 2024Buy$10.00450,0004,500,0008,393,520Mar 15, 2024, 04:15 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerFeb 14, 2024Sale$14.90136,6422,035,966635,341Feb 16, 2024, 04:15 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerFeb 14, 2024Sale$14.90688,35810,256,5343,200,634Feb 16, 2024, 04:15 PM
SKYESkye Bioscience, Inc.PARMAR KUSH10% OwnerJan 31, 2024Buy$2.315,206,07412,026,0317,943,520Feb 02, 2024, 04:32 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerJan 31, 2024Sale$15.0082,8131,242,195771,983Feb 02, 2024, 04:29 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerJan 31, 2024Sale$15.00417,1876,257,8053,888,992Feb 02, 2024, 04:29 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerSep 26, 2023Sale$15.0032,711490,665854,796Sep 28, 2023, 04:27 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerSep 26, 2023Sale$15.00164,7892,471,8354,306,179Sep 28, 2023, 04:27 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerAug 24, 2023Sale$16.0072,8761,166,016887,507Aug 28, 2023, 04:20 PM
ELVNEnliven Therapeutics, Inc.PARMAR KUSH10% OwnerAug 24, 2023Sale$16.00367,1245,873,9844,470,968Aug 28, 2023, 04:20 PM
RLYBRallybio CorpPARMAR KUSHDirectorMar 07, 2023Sale$8.20100,000820,0002,378,969Mar 09, 2023, 04:39 PM
CINCCinCor Pharma, Inc.PARMAR KUSH10% OwnerAug 15, 2022Buy$30.00487,33314,619,990487,333Aug 17, 2022, 08:01 PM
CINCCinCor Pharma, Inc.PARMAR KUSH10% OwnerAug 15, 2022Buy$30.00112,6673,380,0103,953,990Aug 17, 2022, 08:01 PM
RLYBRallybio CorpPARMAR KUSHDirectorJun 03, 2022Sale$12.5050,329629,1131,251,755Jun 07, 2022, 05:03 PM
RLYBRallybio CorpPARMAR KUSHDirectorJun 03, 2022Sale$12.5099,6711,245,8882,478,969Jun 07, 2022, 05:03 PM
RLYBRallybio CorpPARMAR KUSHDirectorMay 23, 2022Sale$13.0033,553436,1891,302,084May 25, 2022, 06:34 PM
RLYBRallybio CorpPARMAR KUSHDirectorMay 23, 2022Sale$13.0066,447863,8112,578,640May 25, 2022, 06:34 PM
RLYBRallybio CorpPARMAR KUSHDirectorFeb 08, 2022Sale$13.0570,461919,5161,335,637Feb 10, 2022, 06:22 PM
RLYBRallybio CorpPARMAR KUSHDirectorFeb 08, 2022Sale$13.05139,5391,820,9842,645,087Feb 10, 2022, 06:22 PM
CINCCinCor Pharma, Inc.PARMAR KUSH10% OwnerJan 11, 2022Buy$16.00312,5005,000,000496,323Jan 13, 2022, 04:45 PM
CINCCinCor Pharma, Inc.PARMAR KUSH10% OwnerJan 11, 2022Buy$16.00157,5002,520,0003,841,323Jan 13, 2022, 04:45 PM
VORVor Biopharma Inc.PARMAR KUSHDirectorNov 16, 2021Sale$15.30330,7065,059,8024,595,089Nov 18, 2021, 08:10 PM
TRDAEntrada Therapeutics, Inc.PARMAR KUSHDirectorNov 02, 2021Buy$20.00250,0005,000,0001,132,357Nov 05, 2021, 08:49 AM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerNov 01, 2021Sale$13.00295,0003,835,0001,731,119Nov 03, 2021, 04:38 PM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerSep 07, 2021Sale$9.70625,0006,062,5001,989,575Sep 09, 2021, 05:34 PM
RLYBRallybio CorpPARMAR KUSHDirectorAug 02, 2021Buy$13.00615,3847,999,9921,406,098Aug 04, 2021, 09:19 PM
VORVor Biopharma Inc.PARMAR KUSHDirectorFeb 09, 2021Buy$18.00555,5559,999,9904,833,959Feb 09, 2021, 05:15 PM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerJan 08, 2021Sale$13.00302,0003,926,0002,689,045Jan 12, 2021, 05:07 PM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerJan 12, 2021Sale$13.0085,0001,105,0002,614,575Jan 12, 2021, 05:07 PM
AKUSAkouos, Inc.PARMAR KUSHDirectorDec 29, 2020Sale$18.00470,0008,460,0003,153,331Dec 31, 2020, 09:32 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorDec 22, 2020Sale$12.82500,0006,410,0004,354,484Dec 28, 2020, 09:37 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorDec 14, 2020Sale$12.25500,0006,125,9155,163,346Dec 16, 2020, 07:25 PM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerDec 10, 2020Sale$14.75298,0004,395,5002,953,634Dec 14, 2020, 05:58 PM
FVAM5:01 Acquisition Corp.PARMAR KUSHCo-CEONov 12, 2020Option Exercise$10.005,12651,260365,126Nov 12, 2020, 05:53 PM
FVAM5:01 Acquisition Corp.PARMAR KUSHCo-CEOOct 16, 2020Option Exercise$10.00360,0003,600,000360,000Oct 20, 2020, 08:42 PM
APREAprea Therapeutics, Inc.PARMAR KUSHFormer 10% holderOct 05, 2020Sale$25.30175,0004,427,500138,497Oct 07, 2020, 09:30 PM
AKUSAkouos, Inc.PARMAR KUSHDirectorJun 30, 2020Buy$17.00294,1174,999,9891,094,101Jul 02, 2020, 12:00 AM
APREAprea Therapeutics, Inc.PARMAR KUSH10% OwnerJun 16, 2020Sale$33.30140,0004,662,0001,823,192Jun 18, 2020, 07:22 PM
APREAprea Therapeutics, Inc.PARMAR KUSH10% OwnerJun 11, 2020Sale$28.75245,0007,044,4121,938,549Jun 15, 2020, 09:12 PM
APREAprea Therapeutics, Inc.PARMAR KUSH10% OwnerMay 19, 2020Sale$35.15255,0008,963,2502,173,748May 21, 2020, 09:31 PM
CABACabaletta Bio, Inc.PARMAR KUSH10% OwnerOct 29, 2019Buy$11.00454,5454,999,995454,545Oct 31, 2019, 06:03 PM
APREAprea Therapeutics, Inc.PARMAR KUSH10% OwnerOct 07, 2019Buy$15.00333,3334,999,995333,333Oct 09, 2019, 06:23 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorMay 16, 2019Sale$21.47615,00013,204,0505,314,484May 20, 2019, 04:24 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorDec 10, 2018Sale$26.0115,575405,0295,904,884Dec 12, 2018, 08:10 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorNov 23, 2018Sale$20.0429,682594,7095,919,836Nov 27, 2018, 06:09 PM
FIXXHomology Medicines, Inc.PARMAR KUSHDirectorNov 16, 2018Sale$20.20525,90010,623,1805,948,331Nov 20, 2018, 05:05 PM